PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 16599026-1 2005 BACKGROUND: Deferiprone (DFP,L1) is a bidentate oral iron chelator which binds to iron in a 3:1 ratio. Iron 53-57 immunoglobulin kappa variable 1-16 Homo sapiens 25-31 17719088-1 2007 In order to probe the DNA-helicate interactions responsible for the DNA binding and remarkable changes of the DNA secondary structure induced by a tetracationic bi-metallo helicate [Fe(2)(L(1))(3)](4+) (L(1)=C(25)H(20)N(4)), we have designed and synthesised derivatives with hydrophobic methyl groups at different positions on the ligand backbone. Iron 182-184 immunoglobulin kappa variable 1-16 Homo sapiens 188-192 17719088-1 2007 In order to probe the DNA-helicate interactions responsible for the DNA binding and remarkable changes of the DNA secondary structure induced by a tetracationic bi-metallo helicate [Fe(2)(L(1))(3)](4+) (L(1)=C(25)H(20)N(4)), we have designed and synthesised derivatives with hydrophobic methyl groups at different positions on the ligand backbone. Iron 182-184 immunoglobulin kappa variable 1-16 Homo sapiens 203-207 16798646-9 2006 Three patients had increased iron scores after therapy of L1 and 11 patients had increased ALT levels; increased ALT levels occurred more frequently in hepatitis C positive patients. Iron 29-33 immunoglobulin kappa variable 1-16 Homo sapiens 58-67 16798647-10 2006 Chelation therapy using L1 or appropriate L1/DFO combinations can reduce cardiac iron overload and the mortality rate in thalassemia patients. Iron 81-85 immunoglobulin kappa variable 1-16 Homo sapiens 42-48 16599026-1 2005 BACKGROUND: Deferiprone (DFP,L1) is a bidentate oral iron chelator which binds to iron in a 3:1 ratio. Iron 82-86 immunoglobulin kappa variable 1-16 Homo sapiens 25-31 12012183-4 2002 The developed methodology was applied to the colorimetric determination of total Fe and Cr (VI) in wastewaters at 0.1-6.0 mg L-1 and 0.03-1.0 mg L-1, respectively. Iron 81-83 immunoglobulin kappa variable 1-16 Homo sapiens 125-134 14658011-3 2004 Furthermore, combined therapy with L1 and DFX produced an additive or synergistic iron chelating effect. Iron 82-86 immunoglobulin kappa variable 1-16 Homo sapiens 35-45 12012183-4 2002 The developed methodology was applied to the colorimetric determination of total Fe and Cr (VI) in wastewaters at 0.1-6.0 mg L-1 and 0.03-1.0 mg L-1, respectively. Iron 81-83 immunoglobulin kappa variable 1-16 Homo sapiens 125-128 7975362-4 1994 Iron excretion after L 1 treatment was approximately 65% of that obtained with Desferal. Iron 0-4 immunoglobulin kappa variable 1-16 Homo sapiens 21-24 7975362-8 1994 An incomplete absorption from gut and some reutilization of chelated iron may be responsible for less potent iron chelation by L 1 in comparison to Desferal. Iron 69-73 immunoglobulin kappa variable 1-16 Homo sapiens 127-130 7975362-8 1994 An incomplete absorption from gut and some reutilization of chelated iron may be responsible for less potent iron chelation by L 1 in comparison to Desferal. Iron 109-113 immunoglobulin kappa variable 1-16 Homo sapiens 127-130 7975366-5 1994 Hydroxypyridones, especially 1,2-dimethyl-3-hydroxypyrid-4-one (L 1-Deferiprone), are the most intensively studied oral iron chelators. Iron 120-124 immunoglobulin kappa variable 1-16 Homo sapiens 64-67 7975366-6 1994 In animal and clinical studies L 1 administration caused iron excretion comparable to that obtained by desferrioxamine, however, some serious adverse effects (including agranulocytosis) related to L 1 treatment were observed. Iron 57-61 immunoglobulin kappa variable 1-16 Homo sapiens 31-34 32043994-10 2020 The presence of iron (0-1 mg L-1) caused a decrease in the diffusion coefficients, but with regard to the common concentrations of iron (less than 0.3 mg L-1), the negative effect was considered not significant for AsIII and DMA in natural water. Iron 16-20 immunoglobulin kappa variable 1-16 Homo sapiens 29-32 32124285-6 2020 In contrast, extremely fast PrP degradation was achieved through the ZVI/PS process (0.3304 < k < 0.9212 min-1), with removal percentages above 97.5%; in this case, paraben degradation was hindered for a ZVI dosage beyond 40 mg L-1. Iron 69-72 immunoglobulin kappa variable 1-16 Homo sapiens 228-231 31260980-7 2019 Working range (0.01-2 mug L-1 for Cd and 10-500 mug L-1 for Fe) was suitable for the determination of analytes in samples. Iron 60-62 immunoglobulin kappa variable 1-16 Homo sapiens 52-55 31932862-6 2020 The linear range for determination of total iron in terms of Fe3+ was 50-900 mug L-1 with a limit of determination (LOD) of 20 mug L-1 and coefficient of variation (CV) of 3.2%. Iron 44-48 immunoglobulin kappa variable 1-16 Homo sapiens 81-84 31932862-6 2020 The linear range for determination of total iron in terms of Fe3+ was 50-900 mug L-1 with a limit of determination (LOD) of 20 mug L-1 and coefficient of variation (CV) of 3.2%. Iron 44-48 immunoglobulin kappa variable 1-16 Homo sapiens 131-134 31932862-6 2020 The linear range for determination of total iron in terms of Fe3+ was 50-900 mug L-1 with a limit of determination (LOD) of 20 mug L-1 and coefficient of variation (CV) of 3.2%. Iron 61-65 immunoglobulin kappa variable 1-16 Homo sapiens 81-84 31020954-5 2019 Under the optimum conditions, the limits of detection were calculated as 0.08, 0.11, 0.12 and 0.17 mug L-1 for copper, iron, lead and zinc, respectively. Iron 119-123 immunoglobulin kappa variable 1-16 Homo sapiens 103-106 30877547-6 2019 The higher values for these parameters, 0.080 mol Einstein-1 and 0.152 mol Einstein-1, respectively, were obtained with 1.0 g L-1 of the catalyst with the higher iron content (17.6%). Iron 162-166 immunoglobulin kappa variable 1-16 Homo sapiens 126-129 30155753-13 2019 Concurrently, the mean concentrations of Fe and Mn in tube well and channel water are exceeded Cambodian aesthetic guideline of 300 microg L-1 and 100 microg L-1, respectively. Iron 41-43 immunoglobulin kappa variable 1-16 Homo sapiens 139-161 31087924-5 2019 When 1 mmol L-1 formic acid was used and the initial concentration of U(VI) was 50 mg L-1, MIL-53(Fe) achieved a high reduction rate of 80% after 2 hours of visible light exposure. Iron 98-100 immunoglobulin kappa variable 1-16 Homo sapiens 12-15 31087924-5 2019 When 1 mmol L-1 formic acid was used and the initial concentration of U(VI) was 50 mg L-1, MIL-53(Fe) achieved a high reduction rate of 80% after 2 hours of visible light exposure. Iron 98-100 immunoglobulin kappa variable 1-16 Homo sapiens 86-89 30561197-6 2019 The method is linear for iron concentrations in the range of 0.10-6.00 mg L-1 and offers good precision (CV 0.4-10.1%) and low limits of detection (0.02 mg L-1) and quantification (0.06 mg L-1). Iron 25-29 immunoglobulin kappa variable 1-16 Homo sapiens 74-77 30561197-6 2019 The method is linear for iron concentrations in the range of 0.10-6.00 mg L-1 and offers good precision (CV 0.4-10.1%) and low limits of detection (0.02 mg L-1) and quantification (0.06 mg L-1). Iron 25-29 immunoglobulin kappa variable 1-16 Homo sapiens 156-159 30561197-6 2019 The method is linear for iron concentrations in the range of 0.10-6.00 mg L-1 and offers good precision (CV 0.4-10.1%) and low limits of detection (0.02 mg L-1) and quantification (0.06 mg L-1). Iron 25-29 immunoglobulin kappa variable 1-16 Homo sapiens 156-159 28192915-7 2017 The instrument is applicable for multielement analysis, and the LODs ranged from 0.16 to 11.65 mug L-1 for Zn, Pb, Ag, Cd, Au, Cu, Mn, Fe, Cr, and As. Iron 135-137 immunoglobulin kappa variable 1-16 Homo sapiens 99-102 30209767-3 2018 The maximum adsorption capacity of Fe3O4@MOF-100(Fe) for diclofenac sodium can reach 377.36 mg L-1, which was higher than most of the adsorbents reported. Iron 35-37 immunoglobulin kappa variable 1-16 Homo sapiens 95-98 29501031-6 2018 The iron content in ANAMMOX biofilm presented linear correlation with the influent Fe (II) in 1-20 mg L-1, which then tended to be stable when Fe (II) was higher. Iron 4-8 immunoglobulin kappa variable 1-16 Homo sapiens 102-105 28431372-5 2017 With the highest iron concentration (400 mg L-1) applied, the DFSBR achieved 95% of iron removal efficiency. Iron 17-21 immunoglobulin kappa variable 1-16 Homo sapiens 44-47 28431372-5 2017 With the highest iron concentration (400 mg L-1) applied, the DFSBR achieved 95% of iron removal efficiency. Iron 84-88 immunoglobulin kappa variable 1-16 Homo sapiens 44-47 28681287-3 2017 The present study deals with the stability and fate of synthesized zero-valent iron nanoparticles in the upper and lower layers of freshwater microcosm system at a concentration of 1000 mg L-1. Iron 79-83 immunoglobulin kappa variable 1-16 Homo sapiens 189-192 28607404-5 2017 Both MIL-101(Fe) and NH2-MIL-101(Fe) show highly effective removal of phosphates from aqueous solutions, and the concentration of phosphates decrease sharply from the initial 0.60 mg L-1 to 0.045 and 0.032 mg L-1, respectively, within just 30 min of exposure. Iron 13-15 immunoglobulin kappa variable 1-16 Homo sapiens 7-10 28607404-5 2017 Both MIL-101(Fe) and NH2-MIL-101(Fe) show highly effective removal of phosphates from aqueous solutions, and the concentration of phosphates decrease sharply from the initial 0.60 mg L-1 to 0.045 and 0.032 mg L-1, respectively, within just 30 min of exposure. Iron 33-35 immunoglobulin kappa variable 1-16 Homo sapiens 27-30 30148572-11 2017 The predicted values were in good accordance with those determined with inductively coupled plasma atomic emission spectroscopy(ICP-AES) method when the iron ion concentration was above 0.4 mg L-1, which could be used to ascertain the existence of fluorescence quenching agent and their corresponding concentration. Iron 153-157 immunoglobulin kappa variable 1-16 Homo sapiens 193-196 30109676-3 2018 Using a dose of 0.25 g L-1 of Fe, Cu, and Fe/Cu NPs, a degradation efficiency of 13, 26, and 43% respectively was obtained. Iron 30-32 immunoglobulin kappa variable 1-16 Homo sapiens 23-26 30109676-3 2018 Using a dose of 0.25 g L-1 of Fe, Cu, and Fe/Cu NPs, a degradation efficiency of 13, 26, and 43% respectively was obtained. Iron 42-44 immunoglobulin kappa variable 1-16 Homo sapiens 23-26 30109676-8 2018 Fe and Fe/Cu NPs showed the highest efficiency in direct black dye reductive degradation and adsorption of by-products, removing 100% of the dye at a dose of 1 g L-1 within 10 min of reaction. Iron 0-2 immunoglobulin kappa variable 1-16 Homo sapiens 162-165 30109676-8 2018 Fe and Fe/Cu NPs showed the highest efficiency in direct black dye reductive degradation and adsorption of by-products, removing 100% of the dye at a dose of 1 g L-1 within 10 min of reaction. Iron 7-9 immunoglobulin kappa variable 1-16 Homo sapiens 162-165 29753286-7 2018 The amount of iron leached from SFe particles was 4.5 mg L-1, which shows that the SFe catalyst has good stability. Iron 14-18 immunoglobulin kappa variable 1-16 Homo sapiens 57-60 29414334-6 2018 For metals, Fe, Cr, and Rb were dominant in the raw leachate, detected at 7.55, 2.82, and 4.50 mg L-1, respectively. Iron 12-14 immunoglobulin kappa variable 1-16 Homo sapiens 98-101 28672722-4 2017 The increase in iron initial concentration was found to be detrimental, since the natural amount of iron present in the effluent, 73 mg L-1 of total iron and 61 mg L-1 of dissolved iron, was sufficient to ensure the electro-Fenton process at the applied intensities - 0.2-1.4 A. Iron 16-20 immunoglobulin kappa variable 1-16 Homo sapiens 136-139 28672722-4 2017 The increase in iron initial concentration was found to be detrimental, since the natural amount of iron present in the effluent, 73 mg L-1 of total iron and 61 mg L-1 of dissolved iron, was sufficient to ensure the electro-Fenton process at the applied intensities - 0.2-1.4 A. Iron 16-20 immunoglobulin kappa variable 1-16 Homo sapiens 164-167 28672722-4 2017 The increase in iron initial concentration was found to be detrimental, since the natural amount of iron present in the effluent, 73 mg L-1 of total iron and 61 mg L-1 of dissolved iron, was sufficient to ensure the electro-Fenton process at the applied intensities - 0.2-1.4 A. Iron 100-104 immunoglobulin kappa variable 1-16 Homo sapiens 136-139 28672722-4 2017 The increase in iron initial concentration was found to be detrimental, since the natural amount of iron present in the effluent, 73 mg L-1 of total iron and 61 mg L-1 of dissolved iron, was sufficient to ensure the electro-Fenton process at the applied intensities - 0.2-1.4 A. Iron 100-104 immunoglobulin kappa variable 1-16 Homo sapiens 164-167 28672722-4 2017 The increase in iron initial concentration was found to be detrimental, since the natural amount of iron present in the effluent, 73 mg L-1 of total iron and 61 mg L-1 of dissolved iron, was sufficient to ensure the electro-Fenton process at the applied intensities - 0.2-1.4 A. Iron 100-104 immunoglobulin kappa variable 1-16 Homo sapiens 136-139 28672722-4 2017 The increase in iron initial concentration was found to be detrimental, since the natural amount of iron present in the effluent, 73 mg L-1 of total iron and 61 mg L-1 of dissolved iron, was sufficient to ensure the electro-Fenton process at the applied intensities - 0.2-1.4 A. Iron 100-104 immunoglobulin kappa variable 1-16 Homo sapiens 164-167 28672722-4 2017 The increase in iron initial concentration was found to be detrimental, since the natural amount of iron present in the effluent, 73 mg L-1 of total iron and 61 mg L-1 of dissolved iron, was sufficient to ensure the electro-Fenton process at the applied intensities - 0.2-1.4 A. Iron 100-104 immunoglobulin kappa variable 1-16 Homo sapiens 136-139 28672722-4 2017 The increase in iron initial concentration was found to be detrimental, since the natural amount of iron present in the effluent, 73 mg L-1 of total iron and 61 mg L-1 of dissolved iron, was sufficient to ensure the electro-Fenton process at the applied intensities - 0.2-1.4 A. Iron 100-104 immunoglobulin kappa variable 1-16 Homo sapiens 164-167 27770299-5 2017 The addition of iron ions to concentrations of 1 and 10 mg Fe2+ L-1 repressed the finger-type structure and filamentous out-growth. Iron 16-20 immunoglobulin kappa variable 1-16 Homo sapiens 64-67 29964510-11 2017 The maximum concentrations of iron, manganese, ammonium and sulfide in the summer of the El Nino year were 0.38, 1.36, 2.36 and 1.67 mg L-1, respectively. Iron 30-34 immunoglobulin kappa variable 1-16 Homo sapiens 136-139 27865123-5 2017 Log10 reduction on corroded iron pipe wall coupons ranged from 1.0 to 2.9 at respective chlorine dioxide concentrations of 5 and 25 mg L-1, although spores were undetectable on the iron surface during disinfection at 25 mg L-1. Iron 28-32 immunoglobulin kappa variable 1-16 Homo sapiens 135-138 27796971-9 2017 PHREEQC inverse geochemical models showed throughout the upper and middle basin, that about 1.5 mmol L-1 of Fe-bearing minerals were precipitated. Iron 108-110 immunoglobulin kappa variable 1-16 Homo sapiens 101-104 21599430-5 2011 In 2008, specific combinations of L1 and deferoxamine (DFO) were reported to cause the complete removal of excess iron load and the achievement of normal range body iron store levels (NRBISL) in thalassemia patients. Iron 114-118 immunoglobulin kappa variable 1-16 Homo sapiens 34-53 29964685-2 2016 The zero-valent iron dosage was 71 g L-1. Iron 16-20 immunoglobulin kappa variable 1-16 Homo sapiens 37-40 26893541-9 2016 Both L1 and DF could also prevent iron absorption. Iron 34-38 immunoglobulin kappa variable 1-16 Homo sapiens 5-14 27011992-2 2015 With the addition of ZVI, the biological autotrophic denitrification process could be reacted in the influent condition of pH was 7-8, at 35 C +-0.5 C, the concentration of ammonia was 50-100 mg L-1 and the concentration of nitrate was 50-100 mg L-1. Iron 21-24 immunoglobulin kappa variable 1-16 Homo sapiens 197-200 27011992-2 2015 With the addition of ZVI, the biological autotrophic denitrification process could be reacted in the influent condition of pH was 7-8, at 35 C +-0.5 C, the concentration of ammonia was 50-100 mg L-1 and the concentration of nitrate was 50-100 mg L-1. Iron 21-24 immunoglobulin kappa variable 1-16 Homo sapiens 250-253 21166995-4 2012 In anaemic children, 7.0% of males and 15.0% of females were iron deficient (serum ferritin < 15.0 microg L-1). Iron 61-65 immunoglobulin kappa variable 1-16 Homo sapiens 109-112 22534198-3 2012 Under oxic conditions, the degradation of DZP achieved 96% after 60 min using Fe(0) (25 g L(-1)) pre-treated with H(2)SO(4) in the presence of EDTA (119 mg L(-1)), while mineralization achieved around 60% after the same time. Iron 78-83 immunoglobulin kappa variable 1-16 Homo sapiens 90-95 22534198-3 2012 Under oxic conditions, the degradation of DZP achieved 96% after 60 min using Fe(0) (25 g L(-1)) pre-treated with H(2)SO(4) in the presence of EDTA (119 mg L(-1)), while mineralization achieved around 60% after the same time. Iron 78-83 immunoglobulin kappa variable 1-16 Homo sapiens 156-161 21277054-7 2011 Due to high concentrations of Fe (> 0.5 mg L-1), reductive dissolution of Fe oxides is believed to cause As release from aquifer sediments. Iron 30-32 immunoglobulin kappa variable 1-16 Homo sapiens 46-49 21599430-5 2011 In 2008, specific combinations of L1 and deferoxamine (DFO) were reported to cause the complete removal of excess iron load and the achievement of normal range body iron store levels (NRBISL) in thalassemia patients. Iron 165-169 immunoglobulin kappa variable 1-16 Homo sapiens 34-53